Literature DB >> 10557278

Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein.

C Vita1, E Drakopoulou, J Vizzavona, S Rochette, L Martin, A Ménez, C Roumestand, Y S Yang, L Ylisastigui, A Benjouad, J C Gluckman.   

Abstract

Protein-protein interacting surfaces are usually large and intricate, making the rational design of small mimetics of these interfaces a daunting problem. On the basis of a structural similarity between the CDR2-like loop of CD4 and the beta-hairpin region of a short scorpion toxin, scyllatoxin, we transferred the side chains of nine residues of CD4, central in the binding to HIV-1 envelope glycoprotein (gp120), to a structurally homologous region of the scorpion toxin scaffold. In competition experiments, the resulting 27-amino acid miniprotein inhibited binding of CD4 to gp120 with a 40 microM IC(50). Structural analysis by NMR showed that both the backbone of the chimeric beta-hairpin and the introduced side chains adopted conformations similar to those of the parent CD4. Systematic single mutations suggested that most CD4 residues from the CDR2-like loop were reproduced in the miniprotein, including the critical Phe-43. The structural and functional analysis performed suggested five additional mutations that, once incorporated in the miniprotein, increased its affinity for gp120 by 100-fold to an IC(50) of 0.1-1.0 microM, depending on viral strains. The resulting mini-CD4 inhibited infection of CD4(+) cells by different virus isolates. Thus, core regions of large protein-protein interfaces can be reproduced in miniprotein scaffolds, offering possibilities for the development of inhibitors of protein-protein interactions that may represent useful tools in biology and in drug discovery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557278      PMCID: PMC23905          DOI: 10.1073/pnas.96.23.13091

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  CD4: its structure, role in immune function and AIDS pathogenesis, and potential as a pharmacological target.

Authors:  R W Sweet; A Truneh; W A Hendrickson
Journal:  Curr Opin Biotechnol       Date:  1991-08       Impact factor: 9.740

2.  Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.

Authors:  X Zhang; M Gaubin; L Briant; V Srikantan; R Murali; U Saragovi; D Weiner; C Devaux; M Autiero; D Piatier-Tonneau; M I Greene
Journal:  Nat Biotechnol       Date:  1997-02       Impact factor: 54.908

3.  Refined structure of charybdotoxin: common motifs in scorpion toxins and insect defensins.

Authors:  F Bontems; C Roumestand; B Gilquin; A Ménez; F Toma
Journal:  Science       Date:  1991-12-06       Impact factor: 47.728

4.  Identification of the residues in human CD4 critical for the binding of HIV.

Authors:  J Arthos; K C Deen; M A Chaikin; J A Fornwald; G Sathe; Q J Sattentau; P R Clapham; R A Weiss; J S McDougal; C Pietropaolo
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

5.  Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries.

Authors:  M Ferrer; S C Harrison
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

6.  Accurate measurements of coupling constants from two-dimensional nuclear magnetic resonance spectra of proteins and determination of phi-angles.

Authors:  S Ludvigsen; K V Andersen; F M Poulsen
Journal:  J Mol Biol       Date:  1991-02-20       Impact factor: 5.469

7.  Solution conformation of leiurotoxin I (scyllatoxin) by 1H nuclear magnetic resonance. Resonance assignment and secondary structure.

Authors:  J C Martins; W G Zhang; A Tartar; M Lazdunski; F A Borremans
Journal:  FEBS Lett       Date:  1990-01-29       Impact factor: 4.124

8.  HIV type 1 V3 peptide constructs act differently on HIV type 1 infection of peripheral blood lymphocytes and macrophages.

Authors:  A Benjouad; N Seddiki; L Ylisastigui; J C Gluckman
Journal:  AIDS Res Hum Retroviruses       Date:  1997-02-10       Impact factor: 2.205

9.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

10.  Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices.

Authors:  S E Ryu; A Truneh; R W Sweet; W A Hendrickson
Journal:  Structure       Date:  1994-01-15       Impact factor: 5.006

View more
  52 in total

1.  Concerted evolution of structure and function in a miniature protein.

Authors:  J W Chin; A Schepartz
Journal:  J Am Chem Soc       Date:  2001-03-28       Impact factor: 15.419

2.  Crosslinked HIV-1 envelope-CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques.

Authors:  Timothy Fouts; Karla Godfrey; Kathryn Bobb; David Montefiori; Carl V Hanson; V S Kalyanaraman; Anthony DeVico; Ranajit Pal
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-21       Impact factor: 11.205

3.  Motions and structural variability within toxins: implication for their use as scaffolds for protein engineering.

Authors:  Bernard Gilquin; Marjorie Bourgoin; Renée Ménez; Marie-Hélène Le Du; Denis Servent; Sophie Zinn-Justin; André Ménez
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

4.  Protein grafting of an HIV-1-inhibiting epitope.

Authors:  Samuel K Sia; Peter S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-11       Impact factor: 11.205

5.  Designability of alpha-helical proteins.

Authors:  Eldon G Emberly; Ned S Wingreen; Chao Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

6.  Simulation of the interaction between ScyTx and small conductance calcium-activated potassium channel by docking and MM-PBSA.

Authors:  Yingliang Wu; Zhijian Cao; Hong Yi; Dahe Jiang; Xin Mao; Hui Liu; Wenxin Li
Journal:  Biophys J       Date:  2004-07       Impact factor: 4.033

Review 7.  HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth.

Authors:  Priyamvada Acharya; Sabrina Lusvarghi; Carole A Bewley; Peter D Kwong
Journal:  Expert Opin Ther Targets       Date:  2015-02-27       Impact factor: 6.902

8.  Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.

Authors:  Arne Schön; Navid Madani; Jeffrey C Klein; Amy Hubicki; Danny Ng; Xinzhen Yang; Amos B Smith; Joseph Sodroski; Ernesto Freire
Journal:  Biochemistry       Date:  2006-09-12       Impact factor: 3.162

9.  The Ixodes scapularis salivary protein, salp15, prevents the association of HIV-1 gp120 and CD4.

Authors:  Ignacio J Juncadella; Renu Garg; Tonya C Bates; Elias R Olivera; Juan Anguita
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

10.  Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains.

Authors:  Weizao Chen; Yang Feng; Ponraj Prabakaran; Tianlei Ying; Yanping Wang; Jianping Sun; Camila D S Macedo; Zhongyu Zhu; Yuxian He; Victoria R Polonis; Dimiter S Dimitrov
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.